ConductScience.org, home

Paper23958905

The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.

Islam A and 3 others. Am J Trop Med Hyg, 2013. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice. Papers, record 23958905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23958905

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.
PubMed
Journal
Am J Trop Med Hyg
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.61
iCite
Revised in PubMed
2021-10-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Islam AAminul
2Lockhart MMichelle
3Stenos JJohn
4Graves SStephen

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coxiella burnetiiMajor topic
Q FeverMajor topic
Animals
Mice
Mice, SCID
Spleen
Virulence

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112860682Studies on the immunological role of virenose and dihydrohydroxystreptose present in the Coxiella burnetii phase I lipopolysaccharide.Ann N Y Acad Sci2003https://conductscience.org/library/papers/12860682PubMed
212438347Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain.Infect Immun2002https://conductscience.org/library/papers/12438347PubMed
311521057Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.J Endotoxin Res2000https://conductscience.org/library/papers/11521057PubMed
421338377A comparison of methods for extracting DNA from Coxiella burnetii as measured by a duplex qPCR assay.Lett Appl Microbiol2011https://conductscience.org/library/papers/21338377PubMed
522092959Detecting and measuring small numbers of viable Coxiella burnetii.FEMS Immunol Med Microbiol2012https://conductscience.org/library/papers/22092959PubMed
617893129Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.Infect Immun2007https://conductscience.org/library/papers/17893129PubMed
719786560Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever.Infect Immun2009https://conductscience.org/library/papers/19786560PubMed
815477042A growth study of Coxiella burnetii Nine Mile Phase I and Phase II in fibroblasts.FEMS Immunol Med Microbiol2004https://conductscience.org/library/papers/15477042PubMed
912860683Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I.Ann N Y Acad Sci2003https://conductscience.org/library/papers/12860683PubMed
1016481509Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice.Ann N Y Acad Sci2005https://conductscience.org/library/papers/16481509PubMed
1112874353SCID mouse model for lethal Q fever.Infect Immun2003https://conductscience.org/library/papers/12874353PubMed
123988339Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.Infect Immun1985https://conductscience.org/library/papers/3988339PubMed
139364683Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.Vaccine1997https://conductscience.org/library/papers/9364683PubMed
143280724Evidence of functional lymphocytes in some (leaky) scid mice.J Exp Med1988https://conductscience.org/library/papers/3280724PubMed
153794655Overlapping deletion in two spontaneous phase variants of Coxiella burnetii.J Gen Microbiol1986https://conductscience.org/library/papers/3794655PubMed
166622891"Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation.Rev Infect Dis1983https://conductscience.org/library/papers/6622891PubMed
1717156123Analysis of the O-antigen biosynthesis regions of phase II isolates of Coxiella burnetii.FEMS Microbiol Lett2007https://conductscience.org/library/papers/17156123PubMed
1817438029T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice.Infect Immun2007https://conductscience.org/library/papers/17438029PubMed
196607948Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.J Immunol1984https://conductscience.org/library/papers/6607948PubMed
206823332A severe combined immunodeficiency mutation in the mouse.Nature1983https://conductscience.org/library/papers/6823332PubMed

See all 23 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42709868Direct whole-genome sequencing of Coxiella burnetii from environmental samples using a two-step selective enrichment approach.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/42709868PubMed
40586810Bioluminescent imaging to investigate Coxiella burnetii pathogenesis identifies adipose tissue as a host niche for infection.Infect Immun2025https://conductscience.org/library/papers/40586810PubMed
40448839Overview of the Q fever vaccine development: current status and future prospects.Antonie Van Leeuwenhoek2025https://conductscience.org/library/papers/40448839PubMed
38787259Role of Type 4B Secretion System Protein, IcmE, in the Pathogenesis of Coxiella burnetii.Pathogens2024https://conductscience.org/library/papers/38787259PubMed
38267444Natural reversion promotes LPS elongation in an attenuated Coxiella burnetii strain.Nat Commun2024https://conductscience.org/library/papers/38267444PubMed
36422331Characterization of Coxiella burnetii Dugway Strain Host-Pathogen Interactions In Vivo.Microorganisms2022https://conductscience.org/library/papers/36422331PubMed
32817330Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.Infect Immun2020https://conductscience.org/library/papers/32817330PubMed
30800124MyD88 Is Required for Efficient Control of Coxiella burnetii Infection and Dissemination.Front Immunol2019https://conductscience.org/library/papers/30800124PubMed
29922469Characterization of Coxiella burnetii strains from ruminants in a Galleria mellonella host-based model.New Microbes New Infect2018https://conductscience.org/library/papers/29922469PubMed
28438980Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.Infect Immun2017https://conductscience.org/library/papers/28438980PubMed
28217558The SCID Mouse Model for Identifying Virulence Determinants in Coxiella burnetii.Front Cell Infect Microbiol2017https://conductscience.org/library/papers/28217558PubMed
27418426Right on Q: genetics begin to unravel Coxiella burnetii host cell interactions.Future Microbiol2016https://conductscience.org/library/papers/27418426PubMed
27122484
Bayesian Validation of the Indirect Immunofluorescence Assay and Its Superiority to the Enzyme-Linked Immunosorbent Assay and the Complement Fixation Test for Detecting Antibodies against Coxiella burnetii in Goat Serum.
Clin Vaccine Immunol2016https://conductscience.org/library/papers/27122484PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23958905

GET https://conductscience.org/api/papers/v1/23958905/references?page=2